Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pleural Effusion, Malignant 1

Interventions

aldesleukin 2Trastuzumab 2Pharmaceutical Preparations 2Interleukin-2 2Carboplatin 2Bevacizumab 2tocilizumab 1tipifarnib 1romidepsin 1lipoplatin 1Verteporfin 1Valacyclovir 1Tyrosine Kinase Inhibitors 1Sorafenib 1SPI-77, liposomal 1Povidone-Iodine 1Pleurodesis 1Photochemotherapy 1Paclitaxel 1LMB-100 1Interleukin-12 Subunit p35 1Interleukin-12 1Immunotherapy, Adoptive 1Gemcitabine 1Erlotinib Hydrochloride 1Docetaxel 1Decitabine 1Dasatinib 1Cytoreduction Surgical Procedures 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Pleural Effusion, Malignant × SPI-77, liposomal × Clear all
NCT02702700 2019-03-20

PDT-lipo

Centre Hospitalier Universitaire Vaudois

Phase 1 Terminated
1 enrolled
Thoracic

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡